Meryem Temiz-Resitoglu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Meryem Temiz-Resitoglu has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Seyhan Sahan-Firat
Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Turkey
5 shared publications - Bahar Tunctan
Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Türkiye
2 shared publications - Demet Sinem Guden
Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Turkey
2 shared publications - Kafait U. Malik
Department of Pharmacology, Addiction Science, and Toxicology, College of Medicine, the University of Tennessee Health Science Center, Memphis, TN (K.U.M.).
2 shared publications - Nehir Sucu
MERSİN ÜNİVERSİTESİ, TIP FAKÜLTESİ
2 shared publications - Sefika Pinar Senol
Department of Pharmacy Services, Health Services Vocational School, Tarsus University, Tarsus, Türkiye
2 shared publications
Latest Publications
- 23 August 2026
- Published by Taylor & Francis in Polycyclic Aromatic Compounds
- Vol. 46 (8) , 1441-1470
Difluoromethoxy-Substituted Hexahydroquinolines as Multi-Target Anti-Inflammatory Agents: Mechanistic and Metabolomic Insights
1. Inflammation is a complex biological response that plays a pivotal role in the pathogenesis of numerous human diseases. It is broadly classified into acute and chronic forms. Acute inflammation ...
- 23 August 2026
- Published by Taylor & Francis in Polycyclic Aromatic Compounds
- Vol. 46 (8) , 1441-1470
Difluoromethoxy-Substituted Hexahydroquinolines as Multi-Target Anti-Inflammatory Agents: Mechanistic and Metabolomic Insights
1. Inflammation is a complex biological response that plays a pivotal role in the pathogenesis of numerous human diseases. It is broadly classified into acute and chronic forms. Acute inflammation ...
- Open Access
- 1 January 2023
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 48 (4) , 1322-1332
mTOR inhibition modulates apoptosis and oxidative stress in hindlimb ischemia/reperfusion injury
Purpose: Ischemia/reperfusion (I/R)-induced injuries represent serious clinical events regarding profound target organ destructions followed by remote organ complications due to the loss of oxidant/antioxidant balance and apoptosis. Recent studies examining the mammalian target of rapamycin (mTOR) during I/R injury in different organs have remained a matter of debate. The current study aimed to explore further the protective and underlying antiapoptotic and antioxidant mechanisms of mammalian target of rapamycin (mTOR) inhibition in hindlimb (HL) schemia/reperfusion (I/R)injury. Materials and Methods: Occlusion of bilateral hindlimbs for 4 h with tourniquets was carried out under anesthesia to induce I/R for 4 h in rats. Rapamycin (1 mg/kg) or saline (4 mL/kg) was injected intraperitoneally 1 h before reperfusion. Gastrocnemius muscle, kidney, and blood were collected at the end of the experiments for analysis. Muscle and kidney damages were evaluated by measuring protein expression and/or phosphorylation of eukaryotic initiation factor 4E-binding protein 1 (4EBP1), ribosomal protein S6 (rpS6), B-cell lymphoma 2 (Bcl-2), caspase-3, and Bcl-2-associated X protein (Bax) with NADPH oxidase level and total antioxidant capacity in tissues or sera. Results: I/R-induced organ damages were demonstrated by enhanced phosphorylation and/or expression of rpS6, 4EBP1, caspase-3, and Bax with a significant reduction in Bcl-2 accompanied by a decreased total antioxidant capacity and increased level of NADPH oxidase. Administration of rapamycin, an inhibitor mTOR, protected against I/R-mediated injuries. Conclusion: Our findings suggest that the activation of mTOR signaling plays a crucial role in HL I/R-triggered organ damages presumably through the activation of apoptosis as a result of oxidant/antioxidant imbalance.
- 1 January 2023
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 48 (4) , 1322-1332
Open AccessmTOR inhibition modulates apoptosis and oxidative stress in hindlimb ischemia/reperfusion injury
Purpose: Ischemia/reperfusion (I/R)-induced injuries represent serious clinical events regarding profound target organ destructions followed by remote organ complications due to the loss of oxidant/antioxidant balance and apoptosis. Recent studies examining the mammalian target of rapamycin (mTOR) during I/R injury in different organs have remained a matter of debate. The current study aimed to explore further the protective and underlying antiapoptotic and antioxidant mechanisms of mammalian target of rapamycin (mTOR) inhibition in hindlimb (HL) schemia/reperfusion (I/R)injury. Materials and Methods: Occlusion of bilateral hindlimbs for 4 h with tourniquets was carried out under anesthesia to induce I/R for 4 h in rats. Rapamycin (1 mg/kg) or saline (4 mL/kg) was injected intraperitoneally 1 h before reperfusion. Gastrocnemius muscle, kidney, and blood were collected at the end of the experiments for analysis. Muscle and kidney damages were evaluated by measuring protein expression and/or phosphorylation of eukaryotic initiation factor 4E-binding protein 1 (4EBP1), ribosomal protein S6 (rpS6), B-cell lymphoma 2 (Bcl-2), caspase-3, and Bcl-2-associated X protein (Bax) with NADPH oxidase level and total antioxidant capacity in tissues or sera. Results: I/R-induced organ damages were demonstrated by enhanced phosphorylation and/or expression of rpS6, 4EBP1, caspase-3, and Bax with a significant reduction in Bcl-2 accompanied by a decreased total antioxidant capacity and increased level of NADPH oxidase. Administration of rapamycin, an inhibitor mTOR, protected against I/R-mediated injuries. Conclusion: Our findings suggest that the activation of mTOR signaling plays a crucial role in HL I/R-triggered organ damages presumably through the activation of apoptosis as a result of oxidant/antioxidant imbalance.
- Open Access
- 31 March 2022
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 47 (1) , 219-232
Inhibition of mTOR protects against skeletal muscle and kidney injury following hindlimb ischemia-reperfusion in rats by regulating MEK1/ERK1/2 activity
Purpose: We have previously demonstrated that activation of the mammalian target of rapamycin (mTOR)/inhibitory-κB-α/nuclear factor-κB p65 signaling pathway mediates organ injuries through increased oxidative/nitrosative stress and inflammatory response in rat models of hind limb ischemia/reperfusion (HL I/R). Following up our previous findings regarding I/R injury through mammalian target of rapamycin (mTOR), we aimed to focus on the possible interaction between mammalian target of rapamycin (mTOR and mitogen-activated protein kinase kinase (MEK)1/extracellular signal-regulated kinase (ERK) 1/2 pathway in hind limb ischemia/reperfusion (HL I/R) resulting in target and remote organ injuries in the present study. Materials and Methods: Male Wistar rats were divided into four groups. HL I/R was induced by occluding with tourniquets of both hind limbs. Following 4 h, the tourniquets were removed following reperfusion for 4 h. After 4 h of reperfusion blood, kidney, and gastrocnemius muscle were collected. Results: HL I/R caused an increase in phosphorylation and/or expression of rpS6, MEK1, ERK1/2, tumor necrosis factor-α, inducible nitric oxide synthase, gp91phox, p22phox, and nitrotyrosine as well as nitrite levels in gastrocnemius muscle, kidney, and/or serum. Additionally, nicotinamide adenine dinucleotide phosphate oxidase and myeloperoxidase levels were increased in the tissues of rats subjected to HL I/R. Rapamycin, the selective inhibitor of mTOR, abolished all the effects mentioned above caused by HL I/R in the rat’s muscle and kidney. Conclusion: These data suggest that activation of the MEK1/ERK1/2 pathway contributes to mTOR-mediated HL I/R-induced target and remote organ injury.
- 31 March 2022
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 47 (1) , 219-232
Open AccessInhibition of mTOR protects against skeletal muscle and kidney injury following hindlimb ischemia-reperfusion in rats by regulating MEK1/ERK1/2 activity
Purpose: We have previously demonstrated that activation of the mammalian target of rapamycin (mTOR)/inhibitory-κB-α/nuclear factor-κB p65 signaling pathway mediates organ injuries through increased oxidative/nitrosative stress and inflammatory response in rat models of hind limb ischemia/reperfusion (HL I/R). Following up our previous findings regarding I/R injury through mammalian target of rapamycin (mTOR), we aimed to focus on the possible interaction between mammalian target of rapamycin (mTOR and mitogen-activated protein kinase kinase (MEK)1/extracellular signal-regulated kinase (ERK) 1/2 pathway in hind limb ischemia/reperfusion (HL I/R) resulting in target and remote organ injuries in the present study. Materials and Methods: Male Wistar rats were divided into four groups. HL I/R was induced by occluding with tourniquets of both hind limbs. Following 4 h, the tourniquets were removed following reperfusion for 4 h. After 4 h of reperfusion blood, kidney, and gastrocnemius muscle were collected. Results: HL I/R caused an increase in phosphorylation and/or expression of rpS6, MEK1, ERK1/2, tumor necrosis factor-α, inducible nitric oxide synthase, gp91phox, p22phox, and nitrotyrosine as well as nitrite levels in gastrocnemius muscle, kidney, and/or serum. Additionally, nicotinamide adenine dinucleotide phosphate oxidase and myeloperoxidase levels were increased in the tissues of rats subjected to HL I/R. Rapamycin, the selective inhibitor of mTOR, abolished all the effects mentioned above caused by HL I/R in the rat’s muscle and kidney. Conclusion: These data suggest that activation of the MEK1/ERK1/2 pathway contributes to mTOR-mediated HL I/R-induced target and remote organ injury.
- Open Access
- 31 December 2019
- Published by Mersin Universitesi Saglik Bilimleri Dergisi in Mersin Üniversitesi Sağlık Bilimleri Dergisi
- Vol. 12 (3) , 542-552
Polyphenols and targets in age-related disorders; mTOR signalling pathway
Dünya çapında, yaşa bağlı hastalıkların insidansının artmasıyla birlikte mortalite ve morbiditenin de yüksek olması yaşlanmayı yavaşlatan veya geciktiren müdahalelerin geliştirilmesine neden olmaktadır. Son yıllarda yaşa bağlı gelişebilecek bozukluklarla ilgili yapılan araştırmalar mTOR sinyal ileti yolu üzerinde yoğunlaşmıştır. mTOR ve yapısına dahil olduğu kompleksler yaşlanma ile ilişkilendirilen en önemli hücresel sinyal ileti yolu molekülleri olarak kabul edilmektedir. Ayrıca, mTOR inhibitörleri ile ilgili yaşlanma sürecini yavaşlatabildiklerine dair bulguların ortaya çıkması bu konu üzerindeki ilgiyi giderek arttırmaktadır. Bu derlemede, yaşa bağlı gelişebilecek bozukluklarda mTOR sinyal ileti yolunu hedefleyen diyet türevi doğal polifenolik bileşiklerle ilgili güncel bilgiler derlenmiştir. Ayrıca, polifenollerin yaşa bağlı bozukluklarının moleküler patojenezi üzerindeki etkilerinden de bahsedilmiştir.
- 31 December 2019
- Published by Mersin Universitesi Saglik Bilimleri Dergisi in Mersin Üniversitesi Sağlık Bilimleri Dergisi
- Vol. 12 (3) , 542-552
Open AccessPolyphenols and targets in age-related disorders; mTOR signalling pathway
Dünya çapında, yaşa bağlı hastalıkların insidansının artmasıyla birlikte mortalite ve morbiditenin de yüksek olması yaşlanmayı yavaşlatan veya geciktiren müdahalelerin geliştirilmesine neden olmaktadır. Son yıllarda yaşa bağlı gelişebilecek bozukluklarla ilgili yapılan araştırmalar mTOR sinyal ileti yolu üzerinde yoğunlaşmıştır. mTOR ve yapısına dahil olduğu kompleksler yaşlanma ile ilişkilendirilen en önemli hücresel sinyal ileti yolu molekülleri olarak kabul edilmektedir. Ayrıca, mTOR inhibitörleri ile ilgili yaşlanma sürecini yavaşlatabildiklerine dair bulguların ortaya çıkması bu konu üzerindeki ilgiyi giderek arttırmaktadır. Bu derlemede, yaşa bağlı gelişebilecek bozukluklarda mTOR sinyal ileti yolunu hedefleyen diyet türevi doğal polifenolik bileşiklerle ilgili güncel bilgiler derlenmiştir. Ayrıca, polifenollerin yaşa bağlı bozukluklarının moleküler patojenezi üzerindeki etkilerinden de bahsedilmiştir.
- 26 December 2019
- Published by ACG Publications in Bioorganic and Medicinal Chemistry Reports
- Vol. 2 (1-2) , 1-14
Targeting mTOR: up-to-date mTOR inhibitors
MTOR, a member of the phosphatidylinositol 3-kinase-related kinase family, controls major physiological cellular processes such as growth and metabolism in response to nutrients, growth factors, and cellular energy levels. Furthermore, deregulation of the mTOR activity has been associated with various pathological conditions such as cancer, diabetes, obesity, neurological diseases, and genetic disorders. Therefore, research on the mTOR signalling pathway and the development of effective molecules on this pathway has been continuing intensively in recent years. In the past decade, numerous mTOR inhibitors have been developed and many are currently in clinical trials. These molecules are classified as Rapamycin and its analogs (all are termed rapalogs), ATP-competitive dual PI3K/mTOR inhibitors, mTOR kinase inhibitors, and Rapa Links. In this review, we aimed to summarize current findings on mTOR signalling network and molecules acting on this signalling pathway.
- 26 December 2019
- Published by ACG Publications in Bioorganic and Medicinal Chemistry Reports
- Vol. 2 (1-2) , 1-14
Targeting mTOR: up-to-date mTOR inhibitors
MTOR, a member of the phosphatidylinositol 3-kinase-related kinase family, controls major physiological cellular processes such as growth and metabolism in response to nutrients, growth factors, and cellular energy levels. Furthermore, deregulation of the mTOR activity has been associated with various pathological conditions such as cancer, diabetes, obesity, neurological diseases, and genetic disorders. Therefore, research on the mTOR signalling pathway and the development of effective molecules on this pathway has been continuing intensively in recent years. In the past decade, numerous mTOR inhibitors have been developed and many are currently in clinical trials. These molecules are classified as Rapamycin and its analogs (all are termed rapalogs), ATP-competitive dual PI3K/mTOR inhibitors, mTOR kinase inhibitors, and Rapa Links. In this review, we aimed to summarize current findings on mTOR signalling network and molecules acting on this signalling pathway.